GLP-2 TRZ 20MG/3ML VIAL

Tirzepatide — Research Peptide (20mg)

Tirzepatide is a synthetic dual‑agonist research peptide studied for its interaction with GIP and GLP‑1 receptor pathways, making it a key molecule in advanced metabolic and energy‑regulation research. Current scientific interest focuses on its role in glucose‑signaling models, insulin‑related pathways, and multi‑hormonal metabolic modulation within controlled laboratory environments.

Supplied as: 20mg lyophilized powder in a 3ml vial Use: For laboratory research only. Not for human consumption.